Literature DB >> 6315585

Coordinated therapeutic effects of immune modulators and interferon.

I Cerutti, C Chany.   

Abstract

Immune modulators injected 24 h before encephalomyocarditis virus significantly increase antiviral resistance in mice when interferon is administered 1 h after the virus. These immune modulators can be crude bacterial extracts or synthetic drugs. In some cases, the responses are additive; in others, they are clearly cooperative. To protect the mice against the development of 180 TG Crocker sarcomas, the association of bacterial extracts and interferon is highly effective under the condition that the drug concentrations and chronological order and number of injections are well defined. In contrast, the conjunction of interferon and synthetic immune modulators, in particular cimetidine, result in delayed tumor development with no significant change in the final survival rate in the experimental model described here.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6315585      PMCID: PMC264490          DOI: 10.1128/iai.42.2.728-732.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  Mechanisms of macrophage activation by corynebacterium parvum. II. In vivo experiments.

Authors:  R Bomford; G H Christie
Journal:  Cell Immunol       Date:  1975-05       Impact factor: 4.868

2.  Inhibitory effect of a streptococcal preparation (OK-432) on the nucleic acid synthesis in tumor cells in vitro.

Authors:  T Ono; S Kurata; K Wakabayashi; Y Sugawara; M Saito
Journal:  Gan       Date:  1973-02

3.  Effect of cyclomunine on allogeneic responses in mice.

Authors:  J Navarro; J L Touraine; N Simon-LaVoine
Journal:  Transplantation       Date:  1980-10       Impact factor: 4.939

4.  Enhancement of antiviral protection against encephalomyocarditis virus by a combination of isoprinosine and interferon.

Authors:  C Chany; I Cerutti
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

5.  Effect of histamine H2-receptor antagonists on delayed hypersensitivity.

Authors:  J Avella; J E Madsen; H J Binder; P W Askenase
Journal:  Lancet       Date:  1978-03-25       Impact factor: 79.321

6.  Isoprinosine increases the antitumor action of interferon.

Authors:  I Cerutti; C Chany; J F Schlumberger
Journal:  Int J Immunopharmacol       Date:  1979

7.  Use of sarcoma 180/TG to prepare hyperimmune ascitic fluid in the mouse.

Authors:  A C Sartorelli; D S Fischer; W G Downs
Journal:  J Immunol       Date:  1966-04       Impact factor: 5.422

8.  Isoprinosine augmentation of phytohemagglutinin-induced lymphocyte proliferation.

Authors:  J W Hadden; E M Hadden; R G Coffey
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

9.  Mouse interferons: production by Ehrlich ascites tumour cells infected with Newcastle disease virus and its enhancement by theophylline.

Authors:  E Slattery; H Taira; R Broeze; P Lengyel
Journal:  J Gen Virol       Date:  1980-07       Impact factor: 3.891

10.  Purification of highly radioactive mouse interferon produced by Ehrlich ascites tumour cells induced by Sendai virus.

Authors:  E Dussaix; A Gregoire; C Chany; D C Thang; M N Thang
Journal:  J Gen Virol       Date:  1983-02       Impact factor: 3.891

View more
  1 in total

1.  Adjuvants et stimulants de l'immunité: propriétés immunorégulatrices du muramyl-dipeptide, des corynébactéries anaérobies et du diéthyldithiocarbamate de sodium.

Authors:  D Archambault; G Morin
Journal:  Can Vet J       Date:  1988-01       Impact factor: 1.008

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.